13D/13G Filings - AN2 Therapeutics Inc. (ANTX)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto 0, 1, Next
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2025-02-28
7:57 pm
Sale
2024-12-3113GAN2 Therapeutics, Inc.
ANTX
Adjuvant Global Health Technology Fund, L.P.2,373,500
7.900%
-100,000decrease
(-4.04%)
Filing
History
2025-02-14
6:27 pm
Sale
2024-12-3113GAN2 Therapeutics, Inc.
ANTX
RA Capital Management, L.P.0
0.000%
-1,999,997decrease
(Position Closed)
Filing
History
2025-02-14
4:44 pm
Sale
2024-12-3113GAN2 Therapeutics, Inc.
ANTX
TCG Crossover GP I, LLC0
0.000%
-1,555,118decrease
(Position Closed)
Filing
History
2025-02-14
4:30 pm
Sale
2024-12-3113GAN2 Therapeutics, Inc.
ANTX
Brii Biosciences Limited927,201
3.100%
-121,278decrease
(-11.57%)
Filing
History
2025-02-14
11:07 am
Unchanged
2024-12-3113GAN2 Therapeutics, Inc.
ANTX
Frazier Life Sciences Public Fund, L.P. 0
0.000%
0
(Unchanged)
Filing
History
2025-02-13
4:30 pm
Purchase
2024-12-3113GAN2 Therapeutics, Inc.
ANTX
Easom Eric1,893,132
6.200%
320,962increase
(+20.42%)
Filing
History
2025-02-13
4:28 pm
Unchanged
2024-12-3113GAN2 Therapeutics, Inc.
ANTX
BML Investment Partners, L.P.5,749,432
19.200%
0
(Unchanged)
Filing
History
2024-11-14
4:29 pm
Sale
2024-09-3013GAN2 Therapeutics, Inc.
ANTX
BIOTECHNOLOGY VALUE FUND L P0
0.000%
-1,563,963decrease
(Position Closed)
Filing
History
2024-11-14
4:16 pm
Sale
2024-09-3013GAN2 Therapeutics, Inc.
ANTX
Citadel Advisors LLC22
0.000%
-1,556,820decrease
(-100.00%)
Filing
History
2024-11-13
4:25 pm
Sale
2024-09-3013GAN2 Therapeutics, Inc.
ANTX
TCG Crossover GP I, LLC1,555,118
5.200%
-1,123,091decrease
(-41.93%)
Filing
History
2024-08-28
4:02 pm
Sale
2024-08-2613GAN2 Therapeutics, Inc.
ANTX
Octagon Capital Advisors LP0
0.000%
-3,009,927decrease
(Position Closed)
Filing
History
2024-08-14
9:00 pm
Purchase
2024-08-1413GAN2 Therapeutics, Inc.
ANTX
BML Investment Partners, L.P.5,749,432
19.300%
1,500,000increase
(+35.30%)
Filing
History
2024-08-13
5:40 pm
Sale
2024-08-0913GAN2 Therapeutics, Inc.
ANTX
RA Capital Management, L.P.1,999,997
6.700%
-3,551,298decrease
(-63.97%)
Filing
History
2024-08-12
4:48 pm
Purchase
2024-08-0913GAN2 Therapeutics, Inc.
ANTX
BML Investment Partners, L.P.4,249,432
14.200%
4,249,432increase
(New Position)
Filing
History
2024-07-03
08:02 am
Purchase
2024-06-1313GAN2 Therapeutics, Inc.
ANTX
Octagon Capital Advisors LP3,009,927
10.100%
3,009,927increase
(New Position)
Filing
History
2024-04-10
4:44 pm
Purchase
2024-04-0313GAN2 Therapeutics, Inc.
ANTX
Frazier Life Sciences Public Fund, L.P. 1,488,889
5.000%
1,488,889increase
(New Position)
Filing
2024-02-14
5:01 pm
Purchase
2023-12-3113GAN2 Therapeutics, Inc.
ANTX
RA Capital Management, L.P.5,551,295
18.700%
1,777,778increase
(+47.11%)
Filing
History
2024-02-14
4:57 pm
Purchase
2023-12-3113GAN2 Therapeutics, Inc.
ANTX
Citadel Advisors LLC1,556,842
5.200%
219,849increase
(+16.44%)
Filing
History
2024-02-14
2:29 pm
Purchase
2023-12-3113GAN2 Therapeutics, Inc.
ANTX
PFIZER INC
PFE
1,362,499
4.580%
1,362,499increase
(New Position)
Filing
History
2024-02-13
5:11 pm
Purchase
2022-12-3113GAN2 Therapeutics, Inc.
ANTX
Easom Eric1,572,170
5.200%
1,572,170increase
(New Position)
Filing
History
Goto 0, 1, Next